arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

InflaRx N.V.

IFRX Health Care Biotechnology: Pharmaceutical Preparations
$2.22
Today
as of Sep 4, 16:50 ET
Last 30 days +31.36% Jul 28 → Sep 04
$1.59 $1.82 $2.06 $2.29 $2.52 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$2.21
High
$2.38
Low
$2.16
Volume
$393,941
Avg Vol
$2M
Mkt Cap
$296M
P/E (TTM)
—
Beta
—
52w High
$2.95
52w Low
$0.80
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 3 items

Aug 20 · 11:30 PR GlobeNewswire
InflaRx Announces Participation in September Investor Conferences
Aug 6 · 11:30 PR GlobeNewswire
InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones
Jul 30 · 11:30 PR GlobeNewswire
InflaRx to Report Second Quarter 2026 Results on August 6, 2026

Overview

52-week range
$0.80
$2.95
66% of range
Avg surprise (last 3)
+23.1%
Avg reaction (last 2)
+9.7%
50% positive
Latest IV / EM
263%
EM ±42.6% · $2 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.24$-0.20$-0.16$-0.13$-0.09 Actual $-0.14Est $-0.18Actual $-0.24Est $-0.24Actual $-0.09Est $-0.17 Mar/2025Jun/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 6, 2026Mar/2026 $-0.09 $-0.17 +47.1% +35.7% +26.9% earnings
Thu Aug 7, 2025Jun/2025 $-0.24 $-0.24 0.0% — — earnings
Wed May 7, 2025Mar/2025 $-0.14 $-0.18 +22.2% — -7.5% earnings

Implied volatility — last 90 days

64%169%275%380%485% Jun 08 — IV 465% · EM ±61.4%Jun 09 — IV 486% · EM ±60.8%Jun 19 — IV 138% · EM ±30.4%Jun 22 — IV 146% · EM ±30.4%Jun 23 — IV 266% · EM ±54.4%Jun 24 — IV 65% · EM ±13.0%Jun 25 — IV 66% · EM ±13.0%Jun 30 — IV 233% · EM ±40.2%Jul 01 — IV 141% · EM ±23.6%Jul 02 — IV 146% · EM ±23.6%Jul 10 — IV 450% · EM ±49.8%Jul 13 — IV 407% · EM ±34.0%Jul 14 — IV 470% · EM ±34.0%Jul 20 — IV 105% · EM ±24.7%Jul 21 — IV 113% · EM ±26.2%Jul 22 — IV 86% · EM ±19.8%Jul 23 — IV 283% · EM ±63.6%Jul 27 — IV 310% · EM ±64.7%Aug 04 — IV 277% · EM ±47.8%Aug 05 — IV 372% · EM ±62.1%Aug 06 — IV 395% · EM ±64.0%Aug 07 — IV 393% · EM ±61.4%Aug 12 — IV 99% · EM ±12.4%Aug 13 — IV 103% · EM ±12.2%Aug 14 — IV 89% · EM ±9.8%Aug 17 — IV 116% · EM ±9.7%Aug 18 — IV 190% · EM ±13.8%Aug 19 — IV 240% · EM ±14.2%Aug 20 — IV 340% · EM ±14.2%Aug 26 — IV 77% · EM ±15.5%Aug 27 — IV 79% · EM ±15.5%Aug 28 — IV 223% · EM ±42.6%Sep 02 — IV 219% · EM ±36.6%Sep 03 — IV 263% · EM ±42.6%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in